Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Tuberous Sclerosis × Sirolimus × Clear all

Phase

Status

Completed 9 Recruiting 3 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vascular Malformations 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peutz-Jeghers Syndrome 1 Pancreatic Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Malignant Solid Tumors 1 Lymphoma, Non-Hodgkin 1 Lymphangioma 1 Lymphangioleiomyomatosis 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leiomyoma 1 Kaposiform Hemangioendothelioma 1 Hodgkin Disease 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangioendothelioma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumors 1

Interventions

Everolimus 2 Surveys and Questionnaires 1 Sirolimus 1 Aspirin 1 Anticonvulsants 1 Activator Appliances 1 Actigraphy 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00490789 2008-04-30

TESSTAL

Cardiff University

Phase 2 Unknown

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡